Literature DB >> 17502049

Current concepts in normal and defective angiogenesis: implications for systemic sclerosis.

Mary Jo Mulligan-Kehoe1, Michael Simons.   

Abstract

Vascular abnormalities are a major component of systemic sclerosis, but little is known about the events or mechanisms that initiate vascular injury and prevent its repair. Early stages of systemic sclerosis are characterized by an exaggerated angiogenic response later replaced by defective wound healing and fibrosis. In this review, we summarize the current knowledge of the angiogenic imbalance in systemic sclerosis.

Entities:  

Mesh：

Year:  2007        PMID： 17502049     DOI： 10.1007/s11926-007-0013-2

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


  59 in total

1.  Increased expression of basic fibroblast growth factor in skin of patients with systemic sclerosis.

Authors:  A Lawrence; D Khanna; R Misra; A Aggarwal
Journal:  Dermatol Online J       Date:  2006-01-27

2.  Defective vasculogenesis in systemic sclerosis.

Authors:  Masataka Kuwana; Yuka Okazaki; Hidekata Yasuoka; Yutaka Kawakami; Yasuo Ikeda
Journal:  Lancet       Date:  2004 Aug 14-20       Impact factor: 79.321

3.  Pigment epithelium-derived factor: a potent inhibitor of angiogenesis.

Authors:  D W Dawson; O V Volpert; P Gillis; S E Crawford; H Xu; W Benedict; N P Bouck
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

Review 4.  Autoantigenic posttranslational modifications of proteins: does it apply to rheumatoid arthritis?

Authors:  ZhiJie Zhou; Henri-André Ménard
Journal:  Curr Opin Rheumatol       Date:  2002-05       Impact factor: 5.006

5.  Extracellular matrix remodeling by human granzyme B via cleavage of vitronectin, fibronectin, and laminin.

Authors:  Marguerite S Buzza; Laura Zamurs; Jiuru Sun; Catherina H Bird; A Ian Smith; Joseph A Trapani; Christopher J Froelich; Edouard C Nice; Phillip I Bird
Journal:  J Biol Chem       Date:  2005-04-19       Impact factor: 5.157

6.  Antibodies to membranes of endothelial cells and fibroblasts in scleroderma.

Authors:  M B Hill; J L Phipps; R J Cartwright; A Milford Ward; M Greaves; P Hughes
Journal:  Clin Exp Immunol       Date:  1996-12       Impact factor: 4.330

7.  Antiangiogenic activity of the cleaved conformation of the serpin antithrombin.

Authors:  M S O'Reilly; S Pirie-Shepherd; W S Lane; J Folkman
Journal:  Science       Date:  1999-09-17       Impact factor: 47.728

8.  Tumstatin, an endothelial cell-specific inhibitor of protein synthesis.

Authors:  Yohei Maeshima; Akulapalli Sudhakar; Julie C Lively; Kohjiro Ueki; Surender Kharbanda; C Ronald Kahn; Nahum Sonenberg; Richard O Hynes; Raghu Kalluri
Journal:  Science       Date:  2002-01-04       Impact factor: 47.728

9.  Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.

Authors:  M Cutolo; C Pizzorni; M Tuccio; A Burroni; C Craviotto; M Basso; B Seriolo; A Sulli
Journal:  Rheumatology (Oxford)       Date:  2004-03-16       Impact factor: 7.580

10.  A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients.

Authors:  Betti Giusti; Gabriella Fibbi; Francesca Margheri; Simona Serratì; Luciana Rossi; Filippo Poggi; Ilaria Lapini; Alberto Magi; Angela Del Rosso; Marina Cinelli; Serena Guiducci; Bashar Kahaleh; Laura Bazzichi; Stefano Bombardieri; Marco Matucci-Cerinic; Gian Franco Gensini; Mario Del Rosso; Rosanna Abbate
Journal:  Arthritis Res Ther       Date:  2006-07-19       Impact factor: 5.156
View more
  7 in total

Review 1.  Microvascular involvement in systemic sclerosis and systemic lupus erythematosus.

Authors:  Didem Saygin; Kristin B Highland; Adriano R Tonelli
Journal:  Microcirculation       Date:  2019-04       Impact factor: 2.628

2.  Angiogenic activity of sera from interstitial lung disease patients in relation to pulmonary function.

Authors:  Tadeusz M Zielonka; U Demkow; E Radzikowska; B Bialas; M Filewska; K Zycinska; M H Obrowski; J Kowalski; K A Wardyn; E Skopinska-Rozewska
Journal:  Eur J Med Res       Date:  2010-11-04       Impact factor: 2.175

Review 3.  Pathogenic roles of autoantibodies in systemic sclerosis: Current understandings in pathogenesis.

Authors:  Jean-Luc Senécal; Sabrina Hoa; Roger Yang; Martial Koenig
Journal:  J Scleroderma Relat Disord       Date:  2019-09-09

4.  Abnormalities in the regulators of angiogenesis in patients with scleroderma.

Authors:  Laura K Hummers; Amy Hall; Fredrick M Wigley; Michael Simons
Journal:  J Rheumatol       Date:  2009-02-17       Impact factor: 4.666

Review 5.  Vascular disease in scleroderma.

Authors:  Fredrick M Wigley
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

6.  In vivo angiogenesis screening and mechanism of action of novel tanshinone derivatives produced by one-pot combinatorial modification of natural tanshinone mixture from Salvia miltiorrhiza.

Authors:  Zhe-Rui Zhang; Jin-Hang Li; Shang Li; Ai-Lin Liu; Pui-Man Hoi; Hai-Yan Tian; Wen-Cai Ye; Simon Ming-Yuen Lee; Ren-Wang Jiang
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

7.  Gene Profiling in Patients with Systemic Sclerosis Reveals the Presence of Oncogenic Gene Signatures.

Authors:  Marzia Dolcino; Andrea Pelosi; Piera Filomena Fiore; Giuseppe Patuzzo; Elisa Tinazzi; Claudio Lunardi; Antonio Puccetti
Journal:  Front Immunol       Date:  2018-03-06       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.